Optiver Holding’s Pfizer PFE Stock Holding History

Optiver Holding’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21,954	Closed	-$547K	–	2634
2025 Q4	$547K	Buy	+21,954	New	+$554K	﹤0.01%	565
2024 Q3	–	Sell	-7,510	Closed	-$210K	–	1062
2024 Q2	$210K	Buy	+7,510	New	+$207K	﹤0.01%	489

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Optiver Holding's PFE Position: Q1 2026 in Review

Optiver Holding sold out of Pfizer (PFE) in Q1 2026, closing a stake of 21,954 shares — an estimated $547K sold.

Optiver Holding first reported a position in PFE in Q2 2024 and held it in 2 quarters. The position peaked at $547K in Q4 2025. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Optiver Holding reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
Optiver Holding sold 21,954 Pfizer shares in Q1 2026, an estimated $547K.
Optiver Holding first reported a position in Pfizer in Q2 2024 and held it in 2 quarters.
Optiver Holding's Pfizer position peaked at $547K in Q4 2025.
2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.